Turay et al. (52 patients with recent stroke) found, that patients with MAU after acute stroke scored lower on the Scandinavian Stroke Scale than patients without MAU, had a correlation between the daily excretion of albumin and the severity of neurological deficit on admission (r −0.48, p < 0.05), had a lower score on the Barthel Index on Day 90 (median 65 vs. 100, p < 0.01), and had a higher 90 day mortality rate as compared to patients without MAU (45.8% vs. 7.1%) [11]. This evidence concerns the gene ALB and stroke disorder.